Table 3 Pathways and GO terms in discovery and replication with a threshold of FDR < 0.25 in both phase

From: Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk

Source

Pathway/gene set name

Meta-analysis of discovery cohorts

Replication cohort

P-value

FDR

P-value

FDR

KEGG

neuroactive ligand receptor interaction

0.001

0.006

0.013

0.042

Reactome

neuronal system

0.001

0.015

0.014

0.082

 

transmission across chemical synapses

0.003

0.023

0.003

0.028

Gene Oncology

substrate-specific channel activity

<0.001

0.005

0.002

0.004

 

ion channel activity

<0.001

0.005

0.002

0.004

 

substrate-specific transporter activity

0.001

0.006

0.010

0.013

 

cation channel activity

0.002

0.006

0.002

0.008

 

ion transmembrane transporter activity

0.002

0.006

0.004

0.009

 

metal ion transmembrane transporter activity

0.001

0.006

0.002

0.003

 

transmembrane transporter activity

<0.001

0.006

0.007

0.012

 

gated channel activity

0.002

0.006

0.001

0.016

 

substrate-specific transmembrane transporter activity

<0.001

0.006

0.006

0.012

 

cation transmembrane transporter activity

0.001

0.006

0.003

0.006

 

transmembrane receptor activity

0.001

0.007

<0.001

0.006

 

receptor activity

0.017

0.021

0.002

0.007

 

macromolecular complex

0.001

0.008

0.006

0.037

 

protein complex

0.001

0.012

0.006

0.080

 

intrinsic to membrane

0.003

0.022

0.002

0.025

 

intrinsic to plasma membrane

0.004

0.024

0.002

0.030

 

integral to membrane

0.003

0.027

0.002

0.027

 

membrane part

0.005

0.028

0.013

0.050

 

membrane

0.006

0.032

0.024

0.071

 

plasma membrane part

0.009

0.032

0.005

0.030

 

integral to plasma membrane

0.003

0.035

0.002

0.051

 

plasma membrane

0.015

0.044

0.034

0.085